Literature DB >> 30008509

Nonparametric Two-Sample Tests of the Marginal Mark Distribution with Censored Marks.

Brent A Johnson1.   

Abstract

Occasionally, investigators collect auxiliary marks at the time of failure in a clinical study. Because the failure event may be censored at the end of the follow-up period, these marked endpoints are subject to induced censoring. We propose two new families of two-sample tests for the null hypothesis of no difference in mark-scale distribution that allows for arbitrary associations between mark and time. One family of proposed tests is a nonparametric extension of an existing semi-parametric linear test of the same null hypothesis while a second family of tests is based on novel marked rank processes. Simulation studies indicate that the proposed tests have the desired size and possess adequate statistical power to reject the null hypothesis under a simple change of location in the marginal mark distribution. When the marginal mark distribution has heavy tails, the proposed rank-based tests can be nearly twice as powerful as linear tests.

Entities:  

Keywords:  Wilcoxon statistic; copula; induced censoring; log-rank test; marked point process; quantile process; survival analysis

Year:  2017        PMID: 30008509      PMCID: PMC6040226          DOI: 10.1111/sjos.12265

Source DB:  PubMed          Journal:  Scand Stat Theory Appl        ISSN: 0303-6898            Impact factor:   1.396


  6 in total

1.  Tests for comparing mark-specific hazards and cumulative incidence functions.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Lifetime Data Anal       Date:  2004-03       Impact factor: 1.588

2.  The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Biostatistics       Date:  2007-08-17       Impact factor: 5.899

3.  Estimating medical costs from incomplete follow-up data.

Authors:  D Y Lin; E J Feuer; R Etzioni; Y Wax
Journal:  Biometrics       Date:  1997-06       Impact factor: 2.571

Review 4.  Quality adjusted survival analysis.

Authors:  P P Glasziou; R J Simes; R D Gelber
Journal:  Stat Med       Date:  1990-11       Impact factor: 2.373

5.  Cost analysis with censored data.

Authors:  Yijian Huang
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

6.  A quality-of-life-oriented endpoint for comparing therapies.

Authors:  R D Gelber; R S Gelman; A Goldhirsch
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.